2 weeks Ago
TriSalus Life Sciences press release ( NASDAQ: TLSI ): Q4 GAAP EPS of -$0.40 misses by $0.08 .
Revenue of $8.26M (+44.4% Y/Y) beats by $0.
02M . Cash and Cash Equivalents were $8.5 million as of December 31st, 2024.
The company expects existing liquidity sources and the $15 million.
